Načítá se...
Markedly elevated neonatal immunoreactive trypsinogen levels in the absence of cystic fibrosis gene mutations is not an indication for further testing
AIMS: To investigate the immunoreactive trypsinogen (IRT) values above the usual 99th centile laboratory cut‐off and determine the value of offering further testing to those infants with a markedly elevated IRT but no cystic fibrosis transmembrane regulator (CFTR) gene mutation identified by the scr...
Uloženo v:
| Hlavní autoři: | , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BMJ Group
2006
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2065933/ https://ncbi.nlm.nih.gov/pubmed/16243854 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/adc.2005.081349 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|